Allergan joins TriNetX for real-time access to real-world data

By Maggie Lynch

- Last updated on GMT

(Image: Getty/spainter_vfx)
(Image: Getty/spainter_vfx)

Related tags Real world data Real world evidence Patient recruitment Health care

Allergan joined the TriNetX network to gain access to patient populations, protocol, and site identification through real-world data.

Gadi Lachman, CEO of TriNetX told us that the real-world data Allergan will have access to involves clinical data from the electronic medical records (EMR), genomics, and oncology among other things.

TriNetX says its platform provides industry members with access to patient populations​, cohort analysis, and site identification services​. The TriNetX platform includes real-time access to de-identified real-world data​ from more than 135 million patients.

“[Access to real-world data] is core to how protocols are designed and ultimately how a drug goes to market,”​ said Lachman. “There are also platform features that allow pharma and healthcare organizations to collaborate on study opportunities and placement.”

The TriNetX network has partnerships with household pharmaceutical and health care companies like Sanofi​, Pfizer​, Tufts​, and Boston Children’s Hospital. Allergan is the latest to join the other well-known companies in the network.

TriNetX tools

TriNetX recently released tools that enable health research on a wider spectrum. The company currently has a cloud-platform called TNX, which provides longitudinal clinical data and analytics. More tools will be released later this year and will build on the current and new tools available on the TriNetX platform.

TriNetX has said that it is working towards addressing the importance of real-world data to generate real-world evidence, and is aiming to provide access to it through tools on its platform.

To provide this network of data assets TriNetX is partnered with over 80 healthcare organizations in over 16 countries. 

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

2023 State of Clinical Trial Technology Report

2023 State of Clinical Trial Technology Report

Florence Healthcare | 01-Mar-2023 | Insight Guide

Discover the trends shaping clinical trial technology in 2023, from Site Enablement to eISFs, integrations, and site-sponsor collaboration. This report...

Related suppliers

Follow us

Products

View more

Webinars